BioCorRx Inc. (BICX)
OTCMKTS · Delayed Price · Currency is USD
0.243
-0.187 (-43.42%)
Apr 28, 2026, 10:25 AM EST

BioCorRx Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
-3.44-5.11-3.77-4.37-5.21
Upgrade
Depreciation & Amortization
0.080.10.20.140.17
Upgrade
Other Amortization
0.531.10.640.490.48
Upgrade
Asset Writedown & Restructuring Costs
--0.05-0.14
Upgrade
Stock-Based Compensation
0.591.220.280.350.21
Upgrade
Other Operating Activities
0.450.070.030.76-0.03
Upgrade
Change in Accounts Receivable
-0.2500.03-0.03-0
Upgrade
Change in Inventory
-0.01----
Upgrade
Change in Accounts Payable
0.291.440.80.840.7
Upgrade
Change in Unearned Revenue
-0.060.05-0.03-0.03-0.13
Upgrade
Change in Other Net Operating Assets
-0.480.03-0.09-0.190.14
Upgrade
Operating Cash Flow
-2.3-1.1-1.85-2.04-3.54
Upgrade
Capital Expenditures
-----0
Upgrade
Sale (Purchase) of Intangibles
-----0.05
Upgrade
Investing Cash Flow
-----0.05
Upgrade
Short-Term Debt Issued
1.151.130.970.780.7
Upgrade
Long-Term Debt Issued
----0.13
Upgrade
Total Debt Issued
1.151.130.970.780.83
Upgrade
Short-Term Debt Repaid
-0.68-0.01-0.04--
Upgrade
Long-Term Debt Repaid
-0-0-0-0-
Upgrade
Total Debt Repaid
-0.68-0.01-0.04-0-
Upgrade
Net Debt Issued (Repaid)
0.471.120.930.770.83
Upgrade
Issuance of Common Stock
1.88-0.921.252.25
Upgrade
Financing Cash Flow
2.351.121.852.023.08
Upgrade
Net Cash Flow
0.050.02-0-0.02-0.51
Upgrade
Free Cash Flow
-2.3-1.1-1.85-2.04-3.54
Upgrade
Free Cash Flow Margin
-288.28%-14302.07%-2078.60%-954.81%-7332.77%
Upgrade
Free Cash Flow Per Share
-0.12-0.10-0.22-0.28-0.55
Upgrade
Cash Interest Paid
0.520.010.02--
Upgrade
Levered Free Cash Flow
-2.27-0.72-0.88-2.01-2.06
Upgrade
Unlevered Free Cash Flow
-2.27-0.87-0.97-1.83-2.18
Upgrade
Change in Working Capital
-0.511.520.710.580.7
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.